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Aim To determine cytotoxicity and effect of silica-coated 
magnetic nanoparticles (MNPs) on immune response, in 
particular lymphocyte proliferative activity, phagocytic ac-
tivity, and leukocyte respiratory burst and in vitro produc-
tion of interleukin-6 (IL-6) and 8 (IL-8), interferon-gamma 
(IFN-γ), tumor necrosis factor-alpha (TNF-α), and granulo-
cyte macrophage colony stimulating factor (GM-CSF).
Methods Maghemite was prepared by coprecipitation of 
iron salts with ammonia, oxidation with NaOCl and modi-
fied by tetramethyl orthosilicate and aminosilanes. Particles 
were characterized by transmission electron microscopy 
(TEM), dynamic light scattering (DLS), Fourier-transform in-
frared (FTIR), and X-ray photoelectron spectroscopy (XPS). 
Cytotoxicity and lymphocyte proliferative activity were 
assessed using [3H]-thymidine incorporation into DNA of 
proliferating human peripheral blood cells. Phagocytic ac-
tivity and leukocyte respiratory burst were measured by 
flow cytometry; cytokine levels in cell supernatants were 
determined by ELISA.
Results γ-Fe2O3&SiO2-NH2 MNPs were 13 nm in size. Ac-
cording to TEM, they were localized in the cell cytoplasm 
and extracellular space. Neither cytotoxic effect nor sig-
nificant differences in T-lymphocyte and T-dependent B-
cell proliferative response were found at particle concen-
trations 0.12-75 μg/cm2 after 24, 48, and 72 h incubation. 
Significantly increased production of IL-6 and 8, and GM-
CSF cytokines was observed in the cells treated with 3, 15, 
and 75 µg of particles/cm2 for 48 h and stimulated with 
pokeweed mitogen (PHA). No significant changes in TNF-α 
and IFN-γ production were observed. MNPs did not affect 
phagocytic activity of monocytes and granulocytes when 
added to cells for 24 and 48 h. Phagocytic respiratory burst 
was significantly enhanced in the cultures exposed to 75 
µg MNPs/cm2 for 48 h.
Conclusions The cytotoxicity and in vitro immunotoxicity 
were found to be minimal in the newly developed porous 
core-shell γ-Fe2O3&SiO2-NH2 magnetic nanoparticles.
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Superparamagnetic nanoparticles containing both non-
porous and porous shells have been intensively investigat-
ed in recent years with respect to their potential applica-
tions in separation of molecules (1), sensors (2), as contrast 
agents in magnetic resonance imaging (MRI) (3), as well 
as carriers of drugs and biomolecules (4) for diagnostic (5) 
and therapeutic purposes (6).
Magnetic nanoparticles (MNPs), such as magnetite (Fe3O4) 
or maghemite (γ-Fe2O3), received considerable attention for 
their small size, spherical shape, strong magnetic proper-
ties enabling targeting to a specific organ using an external 
magnetic field (7), and rather low toxicity (8). However, neat 
(uncoated) iron oxide particles showed toxicity at high dos-
es, tendency to aggregate, and high nonspecific adsorption 
of biomolecules, which is inacceptable for in vitro or in vivo 
medical applications (9). This can be avoided by surface mod-
ifications, such as grafting (coating) and/or encapsulation of 
MNPs by polymers, which are the most frequently used ma-
terials to improve biocompatibility and stability of the iron 
oxide nanoparticles in aqueous media. Some examples of 
polymers include dextran, poly(vinyl alcohol) (10), chitosan 
(11), poly(methyl methacrylate) (12), poly(ethylene glycol) 
(13), or poly(L-lysine). One of the universal agents to modify 
the iron oxide surface is also silica (14). This chemically inert 
inorganic material has a lot of advantages for biomedical ap-
plications compared to other materials. It is porous, biocom-
patible, modifiable with various functional agents, and has 
no toxicity at moderate concentrations (15); however silica 
dust is harmful if inhaled, and induces silicosis. Silica deriva-
tives can introduce functional groups, eg, NH2, COOH, SH, 
on the iron oxide surface to enable immobilization of target 
biomolecules. Mesoporous silica nanoparticles are thus at-
tractive for drug loading and controlled release (16).
The aim of this research was to synthesize γ-Fe2O3, 
γ-Fe2O3&SiO2, and γ-Fe2O3&SiO2-NH2 MNPs and thorough-
ly characterize them. We also aimed to investigate in vitro 




FeCl2 · 4H2O and FeCl3 · 6H2O were purchased from Flu-
ka (Buchs, Switzerland). Sodium hypochlorite solution (5 
wt.%) was from Bochemie (Bohumín, Czech Republic). Te-
tramethyl orthosilicate (TMOS), (3-aminopropyl)triethox-
ysilane (APTES), (3-aminopropyl)dimethylethoxysilane (AP-
DMES), RPMI-1640 medium, phytohemagglutinin (PHA), 
concanavalin A (Con A), pokeweed mitogen (PWM), L-
glutamine, and hydroethidine were purchased from Sig-
ma-Aldrich (Steinheim, Germany). Anti-CD3 monoclonal 
antibody was purchased from Beckman Coulter and fetal 
calf serum (FCS) from PAA. Fluorescein-labeled Staphylo-
coccus aureus bacteria and opsonizing reagent were pur-
chased from Molecular Probes (Eugene, OR, USA). Cationic 
surfactant, cetyltrimethylammonium bromide (CTAB) was 
purchased from Lachema (Brno, Czech Republic). Am-
monium hydroxide solution (25%) and ethanol were pur-
chased from Lach-Ner (Neratovice, Czech Republic). Gen-
tamycin was purchased from Sandoz (Bratislava, Slovakia), 
cyclophosphamide (Cyf ) from Baxter (Deerfield, IL, USA), 
and [3H]-thymidine from Moravek Biochemicals (Brea, CA, 
USA). Scintillation fluid was purchased from Perkin Elmer 
(Waltham, MA, USA). Ultrapure Q-water ultrafiltered on a 
Milli-Q Gradient A10 system (Millipore, Molsheim, France) 
was used for preparation of the solutions. ELISA sets were 
purchased from Affymetrix e-Biosciences.
Preparation of γ-Fe2O3 nanoparticles
Iron oxide nanoparticles were prepared from iron(III) chlo-
ride and iron(II) chloride by a standard procedure (17). 
Aqueous 0.2 M FeCl3 (100 mL), 0.2 M FeCl2 (50 mL), and 
0.5 M NH4OH (100 mL) solutions were sonicated (Sonicator 
W-385; Heat Systems-Ultrasonics; Farmingdale, USA) for 5 
min. The mixture was added to 3.3 wt.% NH4OH (460 mL) 
and stirred at 23°C for 1 h (200 rpm). Magnetite was mag-
netically separated and washed by Q-water until peptiza-
tion. Then, 5 wt.% sodium hypochlorite solution (16 mL) 
was added and the system sonicated for 5 min. The precip-
itate was magnetically separated and repeatedly washed 
with Q-water until formation of γ-Fe2O3 colloid.
Synthesis of porous core-shell γ-Fe2O3&SiO2-nH2 
nanoparticles
First, silica shell was introduced on the particles by modi-
fication of Stöber method using hydrolysis and condensa-
tion of TMOS (18). In a typical experiment, ethanol (60 mL), 
water (3 mL), and 25 wt.% ammonia (0.3 mL) were mixed 
with γ-Fe2O3 (150 mg) for 5 min. TMOS (0.1 mL) was added 
and the mixture stirred (400 rpm) at 50°C for 16 h. The re-
sulting γ-Fe2O3&SiO2 colloid was three times washed with 
ethanol using magnetic separation.
The second (porous) shell containing amino groups on the 
surface was introduced by modification of γ-Fe2O3&SiO2 
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nanoparticles with APTES/APDMES mixture (Figure 1). 
Briefly, γ-Fe2O3&SiO2 nanoparticles were dispersed in etha-
nol (60 mL) and CTAB (0.15 g), APTES (0.05 mL), APDMES 
(0.05 mL), and water (1 mL) were added. The mixture was 
stirred using an anchor-type stirrer (400 rpm) at 50°C for 24 
h. After completion of the reaction, the resulting porous 
γ-Fe2O3&SiO2-NH2 particles were washed using magnetic 
separation (5 times with ethanol and 3 times with water) 
and centrifugation (3 times).
Characterization of nanoparticles
The synthesized nanoparticles were characterized by a 
Tecnai Spirit G2 transmission electron microscope (TEM; 
FEI) and number- (Dn) and weight-average particle diam-
eter (Dw) and polydispersity index (PDI = Dw/Dn) were cal-
culated by analyzing ca. 400 particles. The hydrodynamic 
particle size (Dh) of γ-Fe2O3 and γ-Fe2O3&SiO2 and polydis-
persity PI (0-1) was determined by dynamic light scat-
tering (DLS) using a Zetasizer Nano-ZS Model ZEN3600 
instrument (Malvern Instruments; Malvern, UK). Fourier-
transform infrared (FTIR) spectra were recorded in an atten-
uated total reflection (ATR) mode using a Thermo Nicolet 
NEXUS 870 FT-IR Spectrometer (Madison, WI, USA). Specif-
ic surface area (SBET) of the nanoparticles was determined 
by dynamic nitrogen adsorption using a Gemini VII 2390 
Analyzer (Micromeritics; Norcross, GA, USA). X-ray photo-
electron spectroscopy (XPS) was carried out with a K-Al-
pha + spectrometer (ThermoFisher Scientific) equipped 
with a micro-focused monochromated Al Kα X-ray source 
(400 µm spot size). The kinetic energy of the electrons was 
measured using a 180° hemispherical energy analyzer op-
erated in the constant energy mode at 200 and 50 eV pass 
energy for survey and high resolution spectra, respective-
ly. Data acquisition and processing were performed using 
Thermo Advantage software. The XPS spectra were fitted 
with one or more Voigt profiles (binding energy BE, uncer-
tainty ±0.2 eV). The analyzer transmission function, Sco-
field sensitivity factors, and effective attenuation lengths 
for photoelectrons were calculated using the standard 
TPP-2M formalism. All spectra were referenced to the C 1s 
peak of hydrocarbons at 285 eV of BE controlled by means 
of the well-known photoelectron peaks of metallic Cu, Ag, 
and Au.
Participants
Ten healthy male volunteers participating in the study 
signed an informed consent approved by the Ethics 
Committee of the Slovak Medical University in Bratislava. 
Blood was collected by venepuncture using heparinized 
tubes.
Preparation of MnPs for cell treatment
Porous γ-Fe2O3&SiO2-NH2 core-shell nanoparticles were 
vortex-shaken in the tubes for a few minutes before use 
and diluted with the RPMI 1640 medium containing 10% 
FCS to obtain a stock solution (75 µg/cm2). Serial dilutions 
of this solution in the cell culture medium were prepared 
to obtain the full concentration range of MNP dispersions: 
0.12, 0.6, 3, 15, and 75 μg/cm2 corresponding to 0.17, 0.85, 
4.24, 21.2, and 106 μg of particles/mL, respectively. In all 
assays, MNPs were added to the cell cultures in a volume 
of 25 µL.
Interaction of nanoparticles with peripheral blood cells 
according to TeM
Human heparinized whole blood (diluted 1:1 with phos-
phate buffered saline, PBS) was layered on Lymphosep (MP 
Biomedicals) and centrifuged for 30 min (700 g). Mononu-
clear cells were collected from interphase and washed in 
PBS and Roswell Park Memorial Institute medium (RPMI 
1640) with 10% fetal calf serum (FCS). Cells were adjusted 
to 2.5 × 106 cells/mL in RPMI, 10% FCS, and pipetted in six-
plicates in a volume of 180 µL to the microplates. MNPs in 
concentrations 0.12, 3, and 75 µg/cm2 were added in a vol-
FIGure 1. Scheme of silanization of γ-Fe2O3 with tetramethyl orthosilicate (TMOS) and (3-aminopropyl)triethoxysilane/(3-aminopro-
pyl)dimethylethoxysilane (APTeS/APDMeS) to introduce nH2 groups on the particle surface.
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ume of 20 μL. The plates were incubated at 37°C for 24 h 
under 5% CO2 atmosphere. Then the cells were two times 
washed with saline, centrifuged, saline was decanted, and 
the cells were fixed with 2.5% glutaraldehyde in PBS (pH 
7.2) at room temperature for 60 min. Subsequently, the 
cells were washed with PBS and dehydrated with increas-
ing concentration of ethanol (30, 50, 70, 90, 2 × 100%) in 
the solution. The cell pellet was embedded in London Res-
in White (Polysciences; Warrington, PA, USA) and polym-
erized at 60°C for 24 h. Ultrathin sections were prepared 
using LKB ultramicrotome and captured on EM mesh with-
out the support membrane without staining. Ultrathin 
sections were evaluated using a JEOL 1200 EX TEM micro-
scope with 100 kV accelerating voltage.
Assessment of cytotoxicity and immunotoxicity of 
γ-Fe2O3&SiO2-nH2 nanoparticles
Cytotoxicity and proliferative activity of lymphocytes. Cy-
totoxicity and proliferative activity of lymphocytes were 
assessed by 3H-thymidine incorporation into DNA of pro-
liferating cells using a liquid scintillation. Human heparin-
ized whole blood (150 μL) diluted 1:15 in complete RPMI 
1640 medium containing 10% FCS, L-glutamine, and gen-
tamycin was dispensed in triplicate wells of a 96-well mi-
crotiter culture plate under sterile conditions. Mitogens 
were added to obtain the following final concentrations: 
concanavalin A (Con A) (25 μg/mL), phytohemagglutinin 
(PHA) (25 μg/mL), pokeweed mitogen (PWM) (2.5 μg/
mL), and antigen CD3 (3 μg/mL). γ-Fe2O3&SiO2-NH2 nano-
particles (25 μL) were added in different exposure inter-
vals (24, 48, and 72 h) before the end of whole 72 h incu-
bation period. Cyf (40 mg/mL) was used as a suppressive 
control in unstimulated and PHA-stimulated cultures. The 
plates were incubated at 37°C for 48 h under 5% CO2 at-
mosphere; then wells were pulsed with 1 μCi [3H]-thymi-
dine diluted in medium (20 μL) and incubated at 37°C for 
additional 24 h. After the whole 72 h incubation period, 
cell cultures were harvested onto glass filter paper, which 
was placed into a scintillation fluid. Radioactivity was 
measured using a Microbeta 2 scintillation counter (Per-
kin Elmer). Additionally, interference of the nanoparticles 
with the assay was tested, when the particles were added 
to the control cultures (unstimulated or stimulated with 
mitogens and antigen) few minutes before harvesting of 
the cells. Counts per minute (cpm)/per culture were cal-
culated in triplicate for each variable.
In vitro production of interlekin-6 (IL-6), interleukin-8 
(IL-8), interferon-gamma (IFN-γ), tumor necrosis factor-
alpha (TNF-α), and granulocyte macrophage colony-
stimulating factor (GM-CSF). Human heparinized blood 
diluted in complete RPMI-1640 medium (10% FCS) with 
PHA mitogen and the nanoparticles were cultivated for 
72 h as described above. The nanoparticles were added 
24 h after the beginning of the 72 h incubation period. 
After the incubation, cell culture supernatants were re-
moved and frozen at -70°C. The levels of cytokines IL-6, 
IL-8, IFN-γ, TNF-α, and GM-CSF in the cell supernatants 
were analyzed by ELISA according to the manufacturer’s 
procedure.
Phagocytic activity and respiratory burst of leukocytes. 
Phagocytic activity and respiratory burst of leukocytes 
were examined by an Epics XL flow cytometer. Briefly, 150 
μL of human heparinized blood (diluted 1:1 in RPMI-1640 
consisting of 10% FCS, L-glutamine, and gentamycin) was 
distributed into wells of 96-well culture microplate under 
a sterile conditions, γ-Fe2O3&SiO2-NH2 nanoparticles (25 
μL) were added, and the mixture incubated for 24 and 48 
h. Cyf (5 mg/mL) was used as a suppressive control. After 
the incubation, blood (30 μL) from each well was pipetted 
into the tube and hydroethidine solution (10 μL) was add-
ed. First, the samples were incubated at 37°C for 15 min 
and 3 μL of fluorescein-labeled Staphylococcus aureus bac-
teria (1.4 × 106 per test) was added. Second, all tubes were 
incubated at 37°C for another 15 min, the samples were 
put on an ice, and cold lysis solution (700 μL) was added. 
In the control tubes, S. aureus was added after the lysis 
solution. The samples were tested in duplicates and ana-
lyzed by flow cytometry within 30 min as before. Phago-
cytic activity of granulocytes and monocytes and respira-
tory burst of phagocytes were measured. Interference of 
particles with the assay was tested by measuring the same 
control tubes without particles and few seconds after ad-
dition of particles.
Statistical analysis
SPSS 16.0 software (Chicago, IL, USA) was used for sta-
tistical analysis. Triplicates or duplicates from each hu-
man subject were averaged and used as a single value 
for statistical analysis. Normality was determined by Sha-
piro-Wilk test. The paired-sample t test and the Mann-
Whitney U-test (or Wilcoxon’s test) were used to estimate 
significant differences between groups for normally and 
non-normally distributed data, respectively. Data were 
expressed as the mean values with a standard deviation. 
Differences at P < 0.05 were considered to be statistically 
significant.
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reSuLTS
Maghemite nanoparticles (γ-Fe2O3) were prepared accord-
ing to the following reactions:
where magnetite (Fe3O4) was obtained by coprecipitation 
of FeCl2 and FeCl3 by ammonia, which was followed by oxi-
dation. The final product (γ-Fe2O3) was brownish with high 
absolute value of ζ-potential (-41 mV) and exhibiting strong 
magnetization under magnetic field (19). Morphology of 
the resulting products was investigated by TEM, which im-
ages the dry particles (Figure 2). However, drying of aque-
ous colloids always leads to an aggregation. Nevertheless, 
potentially individual almost spherical particles can be dis-
tinguished and their diameters were measured for size sta-
tistics. Diameter of the γ-Fe2O3 particles was 9 nm and the 
particle size distribution was rather narrow (PDI = 1.21). After 
hydrolysis and condensation of TMOS, APTES and APDMES, 
size of the γ-Fe2O3&SiO2-NH2 particles increased to 13 nm 
(Table 1) due to formation of 2 nm-thick silica shell seen as 
a low-contrast layer (Figure 2B). Silica shell increased also the 
hydrodynamic particle diameter from 176 (γ-Fe2O3) to 474 
nm (γ-Fe2O3&SiO2-NH2), while the PI increased from ~0.1 to 
0.2. The reason for such large differences between Dn and Dh 
is that the DLS provides information about the particle dim-
ers and clusters in water, while TEM shows individual par-
ticles in the dry state. DLS measurements of γ-Fe2O3&SiO2-
NH2 nanoparticles incubated with serum at 37.7°C for 24 h 
showed even larger hydrodynamic size ~ 600 nm and size 
distribution PI ~ 0.3-0.4. The γ-Fe2O3&SiO2-NH2 particle col-
loids were stable; a tendency to aggregation was observed 
up to few months of storage. The results from dynamic ad-
sorption of nitrogen are presented in Table 1. The specific sur-
face area increased from 65.9 (neat γ-Fe2O3) to 206 m
2/g for 
γ-Fe2O3&SiO2-NH2 documenting thus porous character of the 
silica shell. Porosity was obviously induced by CTAB present 
in the silanization mixture; after completion of the reaction, 
TABLe 1. Properties of the developed nanoparticles*
Mixed with blood serum after incubation
nanoparticles Dn (nm) PDI Dh (nm) PI Dh (nm) PI SBeT (m
2/g)
γ-Fe2O3  9 1.21 176 0.09 623 0.43  66
γ-Fe2O3&SiO2 10 1.28 260 0.08 - - 167
γ-Fe2O3&SiO2-NH2 13 1.34 474 0.2 598 0.34 206
*Dn – number average particle diameter (TeM), PDI – polydispersity index (TeM), Dh – hydrodynamic diameter (DLS), PI – polydispersity (DLS), SBeT – 
specific surface area.
FIGure 2. Transmission electron micrographs of (A) γ-Fe2O3 and (B) γ-Fe2O3&SiO2-nH2 nanoparticles.
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CTAB was removed from the silica by washing with ethanol 
and water using magnetic separation and centrifugation.
FTIR analysis confirmed successful coating of the neat 
γ-Fe2O3 particles with the silica modification agents (Fig-
ure 3). The spectrum of the γ-Fe2O3 showed absorption 
bands at 3372, 1558, 1418, 896, and 542 cm-1. The range of 
3600-3100 cm-1 was attributed to antisymmetric and sym-
metric O–H stretching, which can suggest the presence of 
adsorbed water on the particle surface (20). Wide peak at 
542 cm-1 is characteristic for the metal oxygen stretching 
vibrations. After the first modification of γ-Fe2O3 nanopar-
ticles with TMOS, the spectrum of γ-Fe2O3&SiO2 confirmed 
the presence of SiO2 shell around the iron oxide cores 
(Figure 3B). Shift of the maximum of Si-O-C asymmetric 
stretching vibration at ~ 1054 cm–1 was ascribed to the in-
teraction of SiO2 with γ-Fe2O3. When the γ-Fe2O3&SiO2 was 
modified with APTES, the spectrum of γ-Fe2O3&SiO2-NH2 
nanoparticles was shifted and the presence of NH2 groups 
was well visible at 1638 and 1472 cm–1; N-H stretching vi-
bration at ~ 3300 cm–1 was only slightly noticeable. The 
peaks at 1480, 1450, and 1395 cm–1 (CH3 deformation vi-
brations) were present in spectra of both γ-Fe2O3&SiO2 and 
γ-Fe2O3&SiO2-NH2 particles.
X-ray photoelectron spectroscopy (XPS)
The XPS results confirmed that the neat γ-Fe2O3 nanopar-
ticles contained Fe and O with Fe/O ratio = 0.55, which is 
close to the theoretically expected value of 0.67 (Table 2; 
Figure 4). The Fe 2p spectrum showed two main peaks at 
710.8 and 724.4 eV corresponding to Fe 2p3/2 and Fe 2p1/2, 
respectively (Figure 4A). These peaks were accompanied by 
weakly pronounced satellite peaks. Importantly, the Fe 2p3/2 
satellite peak (719.0 eV) appeared at separation energy of 8.2 
eV, thus verifying the presence of Fe3+ species. The absence 
of satellite peaks at 716.0 eV characteristic for Fe2+ confirmed 
the absence of Fe3O4 in the nanoparticles. The O 1s spec-
trum of the neat nanoparticles showed two contributions at 
530.0 and 531.3 eV arising from γ-Fe2O3 lattice oxygen and 
surface hydroxyls (Figure 4B). The latter band had contribu-
tions from the adventitious organic carbon contaminants 
originating from alcohol contaminants as further evidenced 
by the peak at 285.0 eV. The Si 2p spectrum of the neat nano-
particles also showed a minute contribution of Si at 101.2 eV 
(Figure 4C). The low intensity of this band made the exact 
identification of the silicon binding state difficult.
The formation of SiO2 shell on the γ-Fe2O3 nanoparticle sur-
face was clearly confirmed by decrease of the Fe and in-
crease of Si and O content in the γ-Fe2O3&SiO2 (Table 2). The 
O 1s and Si 2p regions were characterized by new domi-
nating bands at 533.1 and 104.1 eV, respectively, which are 
typical of pure silica (Figure 4C). Concomitantly, the initially 
observed contributions of γ-Fe2O3 lattice oxygen and sur-
face hydroxyls were significantly lowered.
Introduction of aminosilica (using APTES and APDMES) on 
the nanoparticle surface did not change the O 1s spectra. 
The Si 2p region of the γ-Fe2O3&SiO2-NH2 nanoparticles 
was characterized by a stronger contribution at 102.6 eV 
arising from the Si-C bonds of APTES and APDMES. Impor-
tantly, the high-resolution XPS spectrum in the C 1s and 
N 1s region clearly showed the silane coating containing 
amino terminal groups (Figure 4 D, E). The C 1s envelope of 
TABLe 2. Surface atomic percentages for γ-Fe2O3, γ-Fe2O3&SiO2, and γ-Fe2O3&SiO2-nH2 nanoparticles determined by X-ray photoelec-
tron spectroscopy
Atomic concentration (%)
nanoparticles Fe 2p O 1s C 1s Si 2p n 1s na 1s Cl 2p
γ-Fe2O3 27.7 50.5 17.6  0.8 - 2.5 0.9
γ-Fe2O3&SiO2  8.1 58.1 10.2 23.6 - - -
γ-Fe2O3&SiO2-NH2 12.5 55.9 10.6 20.6 0.4 - -
FIGure 3. Attenuated total reflection Fourier-transform 
infrared spectra of γ-Fe2O3, γ-Fe2O3&SiO2, and γ-Fe2O3&SiO2-nH2 
nanoparticles.
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the silane layer could be resolved into contributions cen-
tered at 284.2, 285.0, 285.7, and 286.5 eV arising from C-Si, 
sp3 carbon (C-C and C-H functionalities), C-N species of 
amines, and C-O contribution of hydroxyls present in the 
non-hydrolyzed ethoxy groups of APTES, respectively. We 
assigned the peak at 288.7 eV to carbamates formed by re-
action of amino groups with atmospheric CO2.
TeM assessment of interaction of γ-Fe2O3&SiO2-nH2 
nanoparticles with peripheral blood cells
TEM micrograph of ultrathin section of peripheral blood 
mononuclear cells treated with the γ-Fe2O3&SiO2-NH2 
nanoparticles showed that they were localized within the 
cytoplasm and in the extracellular space (Figure 5). Micro-
FIGure 4. Measured high resolution (A) Fe 2p, (B) O 1s, (C) Si 2p, (D) C 1s, and (E) n 1s X-ray photoelectron spectra (XPS; black) fitted 
(red) by resolving the individual components (blue). Simulated Fe 2p3/2 spectrum was obtained by considering Gupta-Sen multi-
plets and satellite peaks of high and low binding energy (26). O 1s high-resolution XPS spectra of neat γ-Fe2O3, γ-Fe2O3&SiO2, and 
γ-Fe2O3&SiO2-nH2 nanoparticles showed the presence of surface oxides, hydroxyls, and adsorbed water. Si 2p spectra confirmed 
the formation of SiO2 and SiO2-nH2 shell on the γ-Fe2O3 surface. The presence of amino groups on the γ-Fe2O3&SiO2-nH2 surface was 
further verified by the detailed analysis of the C 1s and n 1s spectra.
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photograph did not display any preferential localization of 
nanoparticles in the cells. Majority of the nanoparticles was 
localized on the cell surface and in cell surroundings.
Assessment of immunotoxicity of γ-Fe2O3&SiO2-nH2 
nanoparticles
Cytotoxicity of γ-Fe2O3&SiO2-NH2 nanoparticles to periph-
eral blood cells and the effect of particles on proliferative 
activity of lymphocytes. In these experiments, cytotoxicity 
and proliferative activity of lymphocytes incubated with 
γ-Fe2O3&SiO2-NH2 nanoparticles was assessed using 
3H-
thymidine incorporation into DNA of proliferating periph-
eral blood cells. Since the particles showed interference 
with the assay (data not shown), cultures with the nano-
particles added few minutes before cell harvesting were 
used as controls for statistical analysis and graphic display 
of the results.
No cytotoxic effect of the newly developed γ-Fe2O3&SiO2-
NH2 core-shell particles on human peripheral blood cells 
was found when the cells were exposed to the whole 
range of particle concentrations (0.12-15 μg/cm2) dur-
ing several time intervals (24, 48, and 72 h). No significant 
differences in basic proliferative activity of cells were ob-
served (Figure 6).
Since no generally accepted nanoparticle positive and 
negative controls for immune assays are available at the 
moment, Cyf (well-known cytotoxic immunosuppressive 
agent) was used in three assays. They included assessment 
of cytotoxicity, proliferative activity of lymphocytes, and 
phagocytic activity of leukocytes. Appropriate doses were 
tested in previous experiments. Cyf (suppressive control) 
exposed to unstimulated peripheral blood cells for 48 and 
72 h displayed a significant cytotoxicity.
In vitro proliferative response of γ-Fe2O3&SiO2-NH2-treated 
human peripheral blood T-lymphocytes and T-dependent 
B-cells after 24, 48, and 72 h exposure was assessed by 
their stimulation with a panel of mitogens and CD3 anti-
gen (Figures 7A-D). Incorporation of [3H]-thymidine into 
FIGure 5. Transmission electron micrograph of ultrathin 
section of blood cells treated with γ-Fe2O3&SiO2-nH2 nanopar-
ticles. They are localized within the cytoplasm of treated cells 
and in the extracellular space. There is no preferential localiza-
tion in the cells, majority of the nanoparticles is localized on 
the cell surface and in cell surroundings. Magnification: 
20 000 × .
FIGure 6. Cytotoxicity of γ-Fe2O3&SiO2-nH2 nanoparticles for human peripheral blood cells determined with [
3H]-thymidine incorpo-
ration assay. results are expressed as counts/min/culture (cpm). Bars indicate mean cpm group values (+ standard deviation) in non-
stimulated cell cultures. Blood cultures were treated with 0 (control), 0.12, 0.6, 3, 15, and 75 μg of γ-Fe2O3&SiO2-nH2/cm
2. The assay 
was performed after 24, 48, and 72 h of in vitro exposure of the peripheral blood cells (n = 10 human volunteers) with γ-Fe2O3&SiO2-
nH2 nanoparticles. Cyf (40 mg/mL) served as a suppressive control. Statistical analysis was performed by comparing cpm in particle-
exposed cultures vs control cultures using Mann-Whitney test, P < 0.001.
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DNA of proliferating cells was highest ( ~ 30 000 cpm) in 
cultures stimulated in vitro with PHA mitogen, as expected 
(Figure 7B). Statistical analysis revealed no significant effect 
of γ-Fe2O3&SiO2-NH2 particle concentration ranging 0.12-15 
μg/cm2 on proliferative activity of lymphocytes stimulated 
with this mitogen in all time intervals. Moreover, regardless 
of the other mitogen and antigen used (Con A, PWM, and 
CD3), no significant changes in proliferative response of 
lymphocytes were found in cultures exposed to the whole 
concentration range of γ-Fe2O3&SiO2-NH2 particles (Figure 7 
A,C,D). A non-significant increase in proliferative response 
of T-cells stimulated through the T-cell receptor with CD3 
antigen was found in the cell cultures treated with low dos-
es of nanoparticles (0.12 µg/mL) for 24, 48, and 72 h (Figure 
7D). Similarly, non-significant increase in proliferation was 
induced by middle concentrations of γ-Fe2O3&SiO2-NH2 
particles (0.6-15 μg/cm2) in cell cultures stimulated with 
Con A (Figure 7A). Non-significant decrease was found also 
in cell cultures containing high dose of particles (75 µg/
cm2) stimulated with PWM mitogen (Figure 7C). The effect 
of suppressive control (Cyf ) on PHA-stimulated cell cultures 
was observed as a significant decrease in proliferative re-
sponse of lymphocytes in all time intervals.
In vitro production of cytokines IL-6, IL-8, IFN-γ, TNF-α, and 
GM-CSF. In vitro production of cytokines IL-6, IL-8, TNF-α, 
IFN-γ, and GM-CSF in cells stimulated with PHA or PWM 
mitogens and treated for 48 h with whole range of parti-
cle concentrations is displayed on Figures 8 A-E. Significant 
increase in production of IL-6 without clear dose-depen-
dence was found in cell cultures in vitro stimulated with 
PHA mitogen and exposed to middle and high particle 
doses (3 and 75 μg/cm2). Similarly, significantly enhanced 
production of IL-8 without clear dose-dependence was 
observed in cells in vitro simulated with the same mitogen 
(PHA) exposed to middle γ-Fe2O3&SiO2-NH2 doses (3 and 
15 μg/cm2). On the other hand, production of IL-8 in PWM 
mitogen-stimulated cultures was significantly suppressed 
in almost all cells exposed to the particles. Levels of IFN-γ 
were significantly elevated in cells in vitro stimulated with 
PWM mitogen treated with two low γ-Fe2O3&SiO2-NH2 dos-
es (0.12 and 0.6 μg/cm2). Regardless of the particle dose 
and mitogen used, production of TNF-α did not differ in 
all experiments. Production of GM-CSF cytokine was sig-
nificantly increased in supernatants derived from cultures 
stimulated with PWM mitogen exposed to the high dose 
of γ-Fe2O3&SiO2-NH2 (75 μg/cm
2).
Phagocytic activity and respiratory burst of leukocytes. 
While the phagocytic activity was evaluated by ingestion 
of fluorescein-labeled Staphylococcus aureus, respiratory 
burst of phagocytes was measured using hydroethidine in 
FIGure 7. Proliferative response of human peripheral blood T-lymphocytes and T-dependent B-cells measured as incorporation of 
[3H]-thymidine (3Tdr) into replicating cells. results are expressed as counts/min/culture (cpm). Bars indicate mean cpm group values 
(+ standard deviation) in cell cultures in vitro stimulated with (A) concanavalin, (B) phytohemagglutinin, (C) pokeweed mitogen, and 
(D) monoclonal anti-CD3 antigen. Blood cultures were treated with 0 (Control), 0.12, 0.6, 3, 15, and 75 μg of γ-Fe2O3&SiO2-nH2/cm
2. 
The assay was performed after 24, 48, and 72 h of in vitro exposure of the peripheral blood cells (n = 10 human volunteers) to par-
ticles. Cyf (40 mg/mL) was used as a suppressive control. Statistical analysis was performed by comparing cpm in particle-exposed 
cell cultures vs control cultures using Mann-Whitney test. Significance: *** P < 0.001.
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the peripheral blood cells in vitro exposed to γ-Fe2O3&SiO2-
NH2 for 24 and 48 h (Figures 9A-C). No interference of par-
ticles with the assay was observed. Phagocytic activity of 
monocytes in γ-Fe2O3&SiO2-NH2-treated cell cultures did 
not show significant changes compared to the control cul-
tures after both 24 and 48 h exposure (Figure 9A). A simi-
lar situation was observed also for the granulocytes (Figure 
9B). Respiratory burst of phagocytes increased with in-
creasing γ-Fe2O3&SiO2-NH2 concentration and was signifi-
cantly enhanced after exposure to high dose of particles 
(75 µg/cm2) after 48 h exposure. Suppressive control agent 
(Cyf ) significantly decreased phagocytic activity of granu-
locytes and respiratory burst of phagocytes in both time 
exposure intervals (24 and 48 h; Figure 9B,C).
DISCuSSIOn
The core-shell γ-Fe2O3&SiO2-NH2 nanoparticles were pre-
pared by chemical coprecipitation, which was followed by 
oxidation and silanization. The coprecipitation technique 
belongs to the most convenient methods for production 
of iron oxide particles, which find many biological appli-
cations, such as in cell imaging and tracking, drug and 
gene delivery, hyperthermia, and capture of various cells 
and biomolecules (21). Morphology including shape, size, 
and its distribution depend on various reaction param-
eters, eg, type of salt, Fe(II)/Fe(III) ratio, temperature, pH, 
ionic strength, stirring, etc. Big advantage of these parti-
cles consists in their superparamagnetic behavior, which 
FIGure 8. In vitro production of (A) interleukin-6, (B) interleukin-8, (C) interferon-gamma, (D) tumor necrosis factor-alpha, and (E) 
granulocyte macrophage colony stimulating factor cytokines in blood cells (n = 8 human volunteers) stimulated with phytohemag-
glutinin and for 48 h exposed to various concentrations of γ-Fe2O3&SiO2-nH2 nanoparticles: 0 (control), 0.12, 0.6, 3, 15, and 75 μg of 
γ-Fe2O3&SiO2-nH2/cm
2. results are expressed as pg/mL. Bars indicate mean group values (+ standard deviation). Statistical analysis 
was performed by comparing cytokine levels in particle-exposed and non-exposed (control) cell culture supernatants using paired t 
test. Significance: * P < 0.05, ** P < 0.01.
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means that below certain size (<20 nm) the particles have 
no hysteresis and are attracted by a magnet, however, they 
are easily redispersed in water when the magnetic field is 
removed (22). In this paper, optimal reaction conditions led 
to formation of 9 nm γ-Fe2O3 particles. After their modifica-
tion with silica and aminosilica, diameter of the particles 
increased to 13 nm. Properties of the starting and modified 
particles were determined by a range of physico-chemical 
methods including TEM, DLS, and XPS measurements. The 
coating on the iron oxide nanoparticle surface was con-
firmed by TEM, ATR FTIR spectroscopy, and XPS analysis. 
Silica coating of the γ-Fe2O3 prevented aggregation of the 
particles in water and enhanced their chemical stability to 
several months.
In the biological in vitro experiments, the cytotoxicity and 
the effect of particles on the immune response were ex-
amined. Five different particle concentrations, which are 
typically used in analogous works, were selected ranging 
0.12-75 µg/cm2, which corresponded to 0.17-106 μg of 
particles/mL (calculated Fe content was from 21.25 ng/mL 
to 13.25 μg/mL). In our experimental setup, γ-Fe2O3&SiO2-
NH2 particles displayed no cytotoxic effect on human pe-
ripheral blood cells. The newly synthesized particles can 
be therefore considered as a nanomaterial with very low 
in vitro cytotoxicity. However, in vivo experiments will be 
needed to confirm the results. Although in vitro and in vivo 
comparison of particle doses is very inaccurate even al-
most impossible; in human clinical diagnostics, the recom-
mended dose for liver imaging is 15 µmol of Fe per kg if 
dextran-coated iron oxide (Endorem) is used.
With the aim to gain an overview on concentrations re-
quired for MR imaging, capacity of human monocytes to 
phagocyte iron oxide of different particle sizes, concen-
trations, and incubation times was investigated (23). The 
intracellular iron content was measured by atomic emis-
sion absorption spectrometry. A significantly higher cellu-
lar iron oxide uptake was found after incubation with large 
compared to small particles. It means that the former par-
FIGure 9. Phagocytic activity of (A) monocytes and (B) granulocytes evaluated by ingestion of fluorescein-labeled Staphylococcus 
aureus, and (C) respiratory burst of phagocytes monitored by flow cytometry using hydroethidine. Bars indicate mean group activity 
(+ standard deviation) in peripheral blood cultures treated in vitro with different concentrations of γ-Fe2O3&SiO2-nH2: 0 (control), 
0.12, 0.6, 3, 15, and 75 μg/cm2; Cyf (5 mg/mL) served as a suppressive control. The assay was performed after 24 and 48 h of in 
vitro exposure of the peripheral blood cells (n = 10 human volunteers) to magnetic particles. Statistical analysis was performed by 
comparing phagocytic activity and respiratory burst in particle-containing samples with control using paired t test. Significance: ** 
P < 0.01, *** P < 0.001.
RECOOP for Common Mechanisms of Diseases 176 Croat Med J. 2016;57:165-78
www.cmj.hr
ticles were better suited for MRI than the latter ones for ex 
vivo labeling of human monocytes prior to injection (23).
Function of lymphocytes was examined in cultures de-
rived from human peripheral blood and in vitro treated ei-
ther with stimulators of T-cells (PHA, Con A mitogens, and 
CD3 antigen) or stimulator of T-dependent B-cell response 
(PWM mitogen). In mitogen-stimulated cultures, differenc-
es in proliferative activity between the particle-exposed 
and unexposed lymphocytes might become more visible. 
This can be attributed to the increased sensitivity of the as-
say due to higher counts per minute per culture. Neverthe-
less, no significant differences in proliferative response of 
T-lymphocytes, as well as T-dependent B-cells, treated with 
all γ-Fe2O3&SiO2-NH2 concentrations compared to the con-
trol untreated cells were found at all time intervals.
Significantly increased production of IL-6, IL-8, and GM-
CSF cytokines by human blood cells treated with middle 
and high doses of γ-Fe2O3&SiO2-NH2 particles (3, 15, and 
75 µg/cm2) were observed in cell cultures stimulated with 
PHA mitogen. However, elevated productions were with-
out clear dose-dependence. This phenomenon can be 
partially explained by different nanoparticle dispersibility 
in the wells resulting in partial agglomeration and variable 
nanoparticle/cell ratios. Absence of γ-Fe2O3&SiO2-NH2 dose 
dependence in stimulation of IL-6, IL-8, and GM-CSF pro-
duction has to be taken into consideration in future inves-
tigations. IL-6 is a pro-inflammatory cytokine secreted by 
T-cells, which stimulates immune response, eg, during in-
fection and after tissue damage leading to inflammation. 
IL-6 is known to stimulate the inflammatory and auto-im-
mune processes in many diseases, such as diabetes or ath-
erosclerosis. IL-8 is a chemokine produced by macrophag-
es and other cell types. IL-8 has two primary functions: 
induction of phagocytosis and chemotaxis, primarily neu-
trophils, but also other granulocytes causing their migra-
tion toward the site of infection. GM-CSF is a white blood 
cell growth factor, which stimulates stem cells to produce 
granulocytes and monocytes. GM-CSF is part of the im-
mune/inflammatory cascade, by which activation of small 
number of macrophages can rapidly lead to an increase in 
their numbers for fighting infection (24).
Results of the effect of γ-Fe2O3&SiO2-NH2 particles on 
phagocytic activity and respiratory burst of phagocytes in 
human peripheral blood cultures are in agreement with 
studies on the interactions of Ferumoxtran-10 (F-10) iron 
oxide with human monocyte-macrophages in vitro, where 
lack of pro-inflammatory activity were assessed (25). After 
72 h incubation, F-10 (1 mg/mL) was not toxic and only 
mildly toxic at high concentrations (10 mg/mL). Viability 
of the cells was not affected during 14 days. F-10 did not 
stimulate cytokines (interleukin-12, interleukin-6, tumor 
necrosis factor-α, and interleukin-1β), superoxide anion 
production, or Fc-receptor-mediated phagocytosis. Simi-
larly, amino-poly(vinyl alcohol)-coated magnetic particles 
did not affect viability of human immune cells, but cy-
tokine secretion (26). At the same time, percentage of vi-
able macrophages increased, especially when the particles 
were added very early in the differentiation process.
On the other hand, magnetic nanoparticles induced for-
mation of membranous ferroportin and incited secretion 
of ferritin, TNF-α, and IL-10 in human histiocytic lympho-
ma cells (U937) and human monocyte leukemia cells with-
out any decrease of cell viability (27). A dose- and time-
dependent cytotoxicity increase of oleate- or oleate/
poly(ethylene glycol)/poly(lactic-co-glycolic acid)-coated 
magnetic particles was found in human lung adenocarci-
noma epithelial (A549) and human embryo lung cells (HEL 
12469) (28).
Animal experiments showed that iron oxide particles ad-
ministered in mice in successive intratracheal instillations 
modulated the pulmonary immune response to oval-
bumin (OVA) depending on the particle dose and size. 
At high and intermediate doses (4 × 250 or 4 × 500 μg of 
nanoparticles/mouse), the OVA-induced allergic response 
was significantly inhibited, as evidenced by the decrease 
in eosinophil cell influx and specific IgE levels. However, 
the low dose (4 × 100 μg of nanoparticles/mouse) had no 
significant effect on the OVA allergic response, while the 
same nanoparticle dose had an adjuvant effect on the Th2 
response to OVA (29).
In conclusion, superparamagnetic γ-Fe2O3 nanoparticles 
were successfully developed and modified with two silica 
precursors. Assessment of interaction of γ-Fe2O3&SiO2-NH2 
nanoparticles with human peripheral blood cells using 
TEM showed that the particles were localized within the 
cytoplasm of treated cells and in the extracellular space. 
No preferential localization in the cells was observed. The 
γ-Fe2O3&SiO2-NH2 particles proved to be non-toxic even 
at high dose (75 µg/cm2) and after long-time incuba-
tion period (72 h). No significant differences in prolifera-
tive response of T-lymphocytes, as well as T-dependent 
B-cells treated with γ-Fe2O3&SiO2-NH2 particles in all con-
centrations and time exposures were found. Significantly 
increased production of IL-6, IL-8, and GM-CSF cytokines 
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by human blood cells treated with middle and high doses 
of γ-Fe2O3&SiO2-NH2 particles (3, 15, and 75 µg/cm
2) was 
observed without clear dose-dependence. No significant 
changes in production of TNF-α and IFN-γ was observed. 
Magnetic nanoparticles did not affect phagocytic activ-
ity of monocytes and granulocytes. Respiratory burst of 
phagocytes was significantly enhanced in cell cultures ex-
posed to high particle dose (75 µg/cm2) for 48 h. Cytotoxic-
ity and in vitro immunotoxicity of new porous γ-Fe2O3&SiO2-
NH2 core-shell nanoparticles were minimal, however, more 
assessments will be needed before possible use in human 
medicine, eg, in cell labeling, MRI, and drug delivery.
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